iBio (IBIO) Long-Term Debt Issuances (2020 - 2025)
iBio's (IBIO) quarterly Long-Term Debt Issuances came in at $17000.0 in Q4 2025, down 60.47% year-on-year from $43000.0 in Q4 2024, and down 63.83% on a QoQ basis from $47000.0 in Q3 2025.
iBio (IBIO) Long-Term Debt Issuances (2020 - 2025) Analysis & Trends
iBio (IBIO) has 5 years of Long-Term Debt Issuances data on file, last reported at $17000.0 in Q4 2025.
- On a quarterly basis, Long-Term Debt Issuances fell 60.47% year-over-year to $17000.0 in Q4 2025; TTM through Mar 2026 was $122000.0, a 6.15% decrease from a year earlier, with the FY2025 full-year figure at $218000.0, up 147.73% from the prior year.
- Long-Term Debt Issuances for Q4 2025 stood at $17000.0, down from $47000.0 in the prior quarter.
- Over the last five years, Long-Term Debt Issuances for IBIO reached as high as $6.2 million in Q4 2022 and fell as low as -$6.2 million in Q1 2023.
- Historically, Long-Term Debt Issuances has averaged $72500.0 across 4 years, with a median of $45000.0 in 2024.
- Across the five-year window, Long-Term Debt Issuances slumped 106.0% in 2024 and soared 293.33% in 2025, its largest moves.
- Year by year, Long-Term Debt Issuances stood at $6.2 million in 2022, then plunged by 98.75% to $78000.0 in 2023, then sank by 44.87% to $43000.0 in 2024, then plunged by 60.47% to $17000.0 in 2025.
- Per Business Quant data, the three most recent Long-Term Debt Issuances figures were $17000.0 in Q4 2025, $47000.0 in Q3 2025, and $58000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,719.23 Bn | 65,718.94 Bn | - | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.85 Bn | 467.06 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 122.29 Bn | 115.04 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.28 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.47 Bn | 959.66 Mn | - |
| 10 | iBio | 167.44 Mn | 167.44 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 17,000.00 |
| Dec 31, 2025 | 17,000.00 |
| Sep 30, 2025 | 47,000.00 |
| Sep 30, 2025 | 47,000.00 |
| Jun 30, 2025 | 58,000.00 |
| Jun 30, 2025 | 58,000.00 |
| Mar 31, 2025 | 74,000.00 |
| Mar 31, 2025 | 74,000.00 |
| Dec 31, 2024 | 43,000.00 |
| Dec 31, 2024 | 43,000.00 |
| Sep 30, 2024 | 43,000.00 |
| Sep 30, 2024 | 43,000.00 |
| Jun 30, 2024 | -30,000.00 |
| Jun 30, 2024 | -30,000.00 |
| Mar 31, 2024 | 40,000.00 |
| Mar 31, 2024 | 40,000.00 |
| Dec 31, 2023 | 78,000.00 |
| Dec 31, 2023 | 78,000.00 |
| Jun 30, 2023 | 500,000.00 |
| Jun 30, 2023 | 500,000.00 |